Redmile Group, LLC
Top Portfolio Positions
35 positions ·
$1,984,563,976 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
18,133,242 | $891,430,176 | 44.92% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
673,505 | $173,979,811 | 8.77% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
4,164,120 | $135,583,747 | 6.83% | |
| IMNM |
Immunome Inc.
Healthcare
|
5,558,885 | $121,572,814 | 6.13% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
7,732,808 | $119,858,524 | 6.04% | |
| ANNX |
Annexon, Inc.
Healthcare
|
14,549,768 | $80,605,714 | 4.06% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
15,470,502 | $58,014,382 | 2.92% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
4,368,804 | $36,610,577 | 1.84% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
5,539,724 | $35,620,425 | 1.79% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
2,892,176 | $30,338,925 | 1.53% |
Portfolio Trend
25 quarters · across all stocks
Holdings in STOK
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $135,583,747 | 4,164,120 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $128,041,381 | 4,034,070 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $98,125,237 | 4,175,542 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $49,666,816 | 4,375,931 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,831,773 | 4,485,981 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,667,727 | 4,593,629 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $57,929,025 | 4,713,509 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $63,781,439 | 4,721,054 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $68,486,161 | 5,073,049 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,810,161 | 2,625,506 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,258,422 | 3,872,696 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,043,648 | 3,955,188 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $34,531,148 | 4,145,396 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,929,628 | 642,430 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,732,057 | 835,830 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,331,070 | 1,993,268 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $42,612,946 | 2,024,368 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $53,897,565 | 2,246,668 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $60,597,011 | 2,381,958 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $82,755,062 | 2,458,558 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $98,811,368 | 2,544,062 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $166,358,471 | 2,686,234 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $85,382,955 | 2,549,506 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $59,629,951 | 2,502,306 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $49,599,980 | 2,165,938 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||